I Lost Fat But Also Muscle (DEXA Scan) GLP-1 Weight Loss

The Number on the Scale Does Not Tell the Full Story

When Losing It Grace shared her DEXA scan results after GLP-1 weight loss, she gave voice to a concern that obesity medicine physicians and exercise scientists have been discussing for years: what exactly are you losing when the scale drops? Her honest, data-driven look at body composition changes on GLP-1 therapy resonated with viewers because it addresses the elephant in the room that most weight loss success stories skip over. Yes, she lost weight. But she also lost muscle. And that matters.

A DEXA scan (dual-energy X-ray absorptiometry) is the gold standard for body composition analysis. Unlike a bathroom scale that gives you one number, or even a body impedance scale that estimates body fat percentage with questionable accuracy, a DEXA scan directly measures bone density, lean tissue mass, and fat mass throughout your body. It shows you exactly where you carry fat and muscle, down to the difference between your left and right arms. When someone shares DEXA data, you are seeing real numbers, not estimates.

The Muscle Loss Problem With GLP-1 Medications

Clinical trial data has consistently shown that weight loss from GLP-1 medications includes a significant component of lean mass (muscle and other non-fat tissue). In the STEP trials for semaglutide, approximately 30-40% of the weight lost was lean mass. For tirzepatide in the SURMOUNT trials, the lean mass loss percentage was similar. This ratio is roughly comparable to what happens with calorie-restricted dieting without medication, but the total amount of lean mass lost is greater because the total weight loss is greater.

Grace's DEXA results illustrated this pattern at an individual level. She lost a meaningful amount of body fat, which improved her metabolic health markers and physical comfort. But she also lost several pounds of lean body mass, primarily muscle. Her body fat percentage improved (because she lost proportionally more fat than muscle), but the absolute muscle loss was enough to notice in her strength, energy levels, and physical appearance.

Why does this matter? Muscle is about more than looking toned. Skeletal muscle is the largest metabolic organ in your body. It is responsible for a significant portion of your resting metabolic rate (the calories you burn just existing). It is the primary site of insulin-mediated glucose disposal (how your body clears sugar from the blood after meals). It protects your joints, supports your skeleton, and maintains your physical independence as you age. Losing muscle during weight loss creates a metabolic penalty that makes weight regain more likely and reduces the metabolic benefits of the weight you lost.

Why GLP-1 Weight Loss Includes Muscle

The muscle loss associated with GLP-1 therapy is not a direct drug effect on muscle tissue. It is a consequence of the severe caloric deficit these medications create through appetite suppression. When you eat significantly fewer calories than your body needs, your body breaks down both fat and muscle for energy. This happens regardless of whether the caloric deficit comes from willpower, a diet program, or medication-suppressed appetite.

The key factor that determines how much muscle you lose relative to fat is protein intake and resistance training. Both are often compromised in GLP-1 patients. Appetite suppression makes it hard to eat enough protein when your total food intake drops dramatically. And many patients who are losing weight rapidly do not prioritize resistance training, either because they were not exercising before starting medication, because they focus on cardio instead, or because reduced caloric intake leaves them feeling too fatigued for intense workouts.

This creates a perfect storm for muscle loss: high caloric deficit plus inadequate protein plus insufficient resistance training stimulus. The medication is not toxic to muscle. The behavior patterns that accompany the medication are what drive the lean mass decline.

How to Protect Your Muscle on GLP-1 Therapy

Grace's video is valuable because she shares more than the problem but what she learned about addressing it. The strategies for preserving muscle during GLP-1 weight loss are well-established in the exercise science literature, even though they require deliberate effort.

Protein intake is the foundation. Most obesity medicine and sports nutrition guidelines recommend consuming at least 0.7 to 1.0 grams of protein per pound of ideal body weight daily during weight loss. For a person targeting a healthy weight of 160 pounds, that means 112 to 160 grams of protein per day. When your total appetite is suppressed and you are eating 1,000-1,200 calories per day, hitting that protein target means that protein needs to be the priority at every meal. Everything else (carbs, fats, fiber) fills in around the protein goal.

Practical protein strategies for GLP-1 patients include starting every meal with the protein component first (before vegetables, grains, or anything else), using protein supplements (whey, casein, or plant-based protein powders) when whole-food protein intake is insufficient, and choosing calorie-efficient protein sources like Greek yogurt, egg whites, chicken breast, fish, and lean turkey. Some patients find that liquid protein (shakes, smoothies) is easier to consume than solid protein when appetite is very suppressed.

Resistance Training Is Non-Negotiable

If protein is the nutritional foundation for muscle preservation, resistance training is the physical foundation. Your muscles respond to mechanical loading. When you lift weights, use resistance bands, or perform bodyweight exercises that challenge your muscles, you send a signal that the muscle tissue is needed and should be preserved even during caloric deficit. Without that signal, your body has no reason to prioritize muscle over fat when breaking down tissue for energy.

The resistance training does not need to be extreme. Two to three sessions per week targeting all major muscle groups is sufficient for muscle preservation during weight loss. The intensity matters more than the volume: you need to work your muscles to near-failure (the point where you cannot complete another rep with good form) to trigger the preservation signal. Light weights with many reps are less effective for this purpose than moderate to heavy weights with fewer reps.

For GLP-1 patients who are new to resistance training, starting with machines at a gym (which guide your movement and reduce injury risk) or working with a personal trainer for the first few weeks is a worthwhile investment. The learning curve is real, but the payoff in muscle preservation is significant.

Monitoring Body Composition Over Time

Grace's decision to use DEXA scans to track her progress is a practice more GLP-1 patients should consider. DEXA scans cost between $75 and $200 depending on your location and provider, and they provide objective data that the bathroom scale cannot. Getting a baseline DEXA before starting GLP-1 therapy, then repeating it every 3-6 months, lets you and your physician track whether you are losing primarily fat or losing too much muscle.

If DEXA scans are not accessible or affordable, other indicators can serve as proxies. Grip strength measured with a simple dynamometer is a validated marker of overall muscle mass and function. The ability to perform basic functional movements (getting up from a chair without using your hands, carrying groceries up stairs, holding a plank for 30 seconds) reflects practical muscle adequacy. Progressive strength improvements in your resistance training program indicate that muscle is being maintained or built rather than lost.

Blood work can also provide clues. Albumin and prealbumin levels reflect protein nutrition status. Creatinine levels (when kidney function is normal) can reflect muscle mass. These are not as precise as DEXA, but they are part of routine lab work that your physician may already be ordering.

The Long-Term Perspective

The muscle loss concern is not a reason to avoid GLP-1 medications. The metabolic benefits of losing significant excess body fat almost certainly outweigh the drawback of some muscle loss, especially when muscle preservation strategies are actively employed. But it is a reason to approach GLP-1 therapy as a full metabolic intervention rather than just a weight loss tool.

The patients who achieve the best long-term outcomes on GLP-1 therapy are those who combine the medication with a protein-prioritized nutrition plan, consistent resistance training, and regular body composition monitoring. They treat the medication as one component of a broader strategy rather than a standalone solution.

Grace's willingness to share her actual DEXA data, including the parts that were not flattering, makes her video more useful than the typical before-and-after transformation post. Real data from real patients drives better decisions. If you are on a GLP-1 medication and have not thought seriously about muscle preservation, this video is the wake-up call you need.

What Grace Changed After Her DEXA Results

The most actionable part of the video is her description of changes after seeing the data. She increased protein intake to approximately 130 grams per day (up from roughly 70 grams), requiring deliberate meal planning and supplementation rather than simply eating whatever fit her suppressed appetite. She started structured resistance training three days per week, focusing on compound movements (squats, deadlifts, rows, presses) that recruit the largest muscle groups. She also added creatine monohydrate at 3-5 grams daily, which has strong evidence for supporting muscle protein synthesis and may be particularly beneficial during caloric deficit.

The results became visible on her follow-up DEXA scan several months later. While she continued losing total body weight at a slower rate, the composition of that loss shifted dramatically. The follow-up showed predominantly fat loss with minimal additional lean mass decline, and in some regions, modest muscle gain. The total weight lost was less impressive than her initial rapid loss, but the quality was dramatically better from a metabolic and body composition standpoint. This is the type of data that changes how patients think about success metrics on GLP-1 therapy.